Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 20 of 1714:
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
Gene Compound Assay Inh Ic50 Ki View
cholinergic receptor, muscarinic 3 DIPHENIDOL Muscarinic M3 97% .245uM .052uM View
nuclear receptor subfamily 3, group C, member 1 ETHISTERONE Glucocorticoid 97% .209uM .095uM View
Protein-tyrosine kinase, Fyn DOBUTAMINE Protein Tyrosine Kinase, Fyn 97% 3.975uM NoneNone View
lymphocyte protein tyrosine kinase (mapped) CLOSANTEL Protein Tyrosine Kinase, Lck 97% 1.249uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 ETHYLESTRENOL Serotonin Transporter 97% .081uM .043uM View
androgen receptor ETHYLESTRENOL Testosterone 97% .027uM .018uM View
A3 adenosine receptor ABAMECTIN Adenosine A3 97% .87uM .492uM View
adrenergic receptor, alpha 2b BENZTROPINE Adrenergic alpha2C 97% .395uM .057uM View
adrenergic receptor, alpha 2c (Non-specific probe) BENZTROPINE Adrenergic alpha2C 97% .395uM .057uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 BENZTROPINE Dopamine Transporter 97% .243uM .193uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DOBUTAMINE Dopamine Transporter 97% .155uM .123uM View
adrenergic receptor, alpha 1b DOBUTAMINE Adrenergic alpha1B 97% .336uM .186uM View
opioid receptor, sigma 1 BROMHEXINE Sigma1 97% .061uM .025uM View
cholinergic receptor, muscarinic 3 MAPROTILINE Muscarinic M3 97% .473uM .1uM View
adrenergic receptor, alpha 2a CLONIDINE Adrenergic alpha2A 97% .28uM .105uM View
cholinergic receptor, muscarinic 1 MAPROTILINE Muscarinic M1 97% .593uM .143uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
gamma-aminobutyric acid A receptor, gamma 1 ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
gamma-aminobutyric acid A receptor, pi ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
AT hook, DNA binding motif, containing 1 (DBSS) ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
gamma-aminobutyric acid A receptor, theta ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
gamma-aminobutyric acid A receptor, gamma 2 ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
sodium channel associated protein 2 SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type III, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type I, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type IX, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type VII, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
amiloride-sensitive cation channel 5, intestinal SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type III, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type XI, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type I, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type 10, alpha polypeptide SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type IV, alpha polypeptide SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type V, alpha polypeptide SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type II, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1 alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1 gamma SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1 beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type XI, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1, gamma SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1, delta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, nonvoltage-gated 1 alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type X, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type IX, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage gated, type VIII, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type VII, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type IV, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type IV, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type III, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type II, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type II, alpha 2 SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type I, beta SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
sodium channel, voltage-gated, type I, alpha SERTRALINE Sodium Channel, Site 2 97% 2.5615uM 2.3368uM View
adrenergic receptor, beta 1 BOPINDOLOL Adrenergic beta1 97% .047uM .027uM View
cholinergic receptor, muscarinic 1 NORTRIPTYLINE Muscarinic M1 97% .082uM .02uM View
cholinergic receptor, muscarinic 3 OLANZAPINE Muscarinic M3 97% .392uM .083uM View
adrenergic receptor, alpha 2b OLANZAPINE Adrenergic alpha2B 97% .421uM .192uM View
cholinergic receptor, muscarinic 4 OLANZAPINE Muscarinic M4 97% .155uM .022uM View
aldo-keto reductase family 1, member B4 (aldose reductase) EPALRESTAT Aldose Reductase 97% .032uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) EPALRESTAT Aldose Reductase 97% .032uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) EPALRESTAT Aldose Reductase 97% .032uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) EPALRESTAT Aldose Reductase 97% .032uM NoneNone View
cholinergic receptor, muscarinic 2 NORTRIPTYLINE Muscarinic M2 97% .347uM .123uM View
5-hydroxytryptamine (serotonin) receptor 2C OLANZAPINE Serotonin 5-HT2C 97% .021uM .011uM View
acetylcholinesterase (YT blood group) OXICONAZOLE Acetylcholinesterase 97% 4.6465uM NoneNone View
dopamine receptor 2 CLOTRIMAZOLE Dopamine D2L 98% 12.186uM 4.062uM View
A3 adenosine receptor CLOTRIMAZOLE Adenosine A3 98% 4.752uM 2.686uM View
cholinergic receptor, muscarinic 1 CLOTRIMAZOLE Muscarinic M1 98% 6.869uM 1.654uM View
adenosine A1 receptor CLOTRIMAZOLE Adenosine A1 98% 13.42uM 7.83uM View
mitogen activated protein kinase 1 TANNIC ACID Protein Serine/Threonine Kinase, ERK2 98% .185uM NoneNone View
mitogen-activated protein kinase 1 TANNIC ACID Protein Serine/Threonine Kinase, ERK2 98% .185uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A CLOTRIMAZOLE Serotonin 5-HT1A 98% 17.688uM 10.108uM View
sodium channel, voltage-gated, type IV, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel associated protein 1 CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel associated protein 2 CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type III, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type I, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type IX, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type VII, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
amiloride-sensitive cation channel 5, intestinal CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type III, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type XI, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type I, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type V, alpha polypeptide CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type II, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, nonvoltage-gated 1 alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, nonvoltage-gated 1 gamma CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, nonvoltage-gated 1 beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type XI, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, nonvoltage-gated 1, gamma CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, nonvoltage-gated 1, delta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type IX, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage gated, type VIII, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type VII, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type IV, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type IV, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type III, alpha CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type II, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type II, alpha 2 CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
sodium channel, voltage-gated, type I, beta CLOTRIMAZOLE Sodium Channel, Site 2 98% 6.771uM 6.071uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
gamma-aminobutyric acid A receptor, alpha 2 ZOPICLONE GABAA, Benzodiazepine, Central 98% .125uM .102uM View
dopamine receptor 2 METERGOLINE Dopamine D2L 98% .063uM .021uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 METERGOLINE Dopamine Transporter 98% .063uM .05uM View
histamine receptor H 1 PROCHLORPERAZINE Histamine H1, Central 98% .024uM .002794uM View
leukotriene B4 receptor 2 PENTAMIDINE Leukotriene B4 98% .242uM .061uM View
leukotriene B4 receptor PENTAMIDINE Leukotriene B4 98% .242uM .061uM View
leukotriene B4 receptor PENTAMIDINE Leukotriene B4 98% .242uM .061uM View
leukotriene B4 receptor 2 PENTAMIDINE Leukotriene B4 98% .242uM .061uM View
adrenergic receptor, alpha 1b PRAZOSIN Adrenergic alpha1B 98% .000178uM .000099uM View
adrenergic receptor, alpha 2c (Non-specific probe) ASTEMIZOLE Adrenergic alpha2C 96% 1.959uM .285uM View
calcium channel, voltage-dependent, gamma subunit 8 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 7 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 6 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 5 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 4 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 3 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 2 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, gamma subunit 1 CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, beta 4 subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, beta 3 subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, beta 2 subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, alpha 1F subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, beta 1 subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CLOMIPHENE Calcium Channel Type L, Benzothiazepine 96% .789uM .701uM View
prostaglandin-endoperoxide synthase 2 KETOROLAC Cyclooxygenase COX-2 96% .424uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) KETOROLAC Cyclooxygenase COX-2 96% .424uM NoneNone View
adrenergic receptor, alpha 2b 4-OCTYLPHENOL Adrenergic alpha2C 96% 14.234uM 2.068uM View
adrenergic receptor, alpha 2c (Non-specific probe) 4-OCTYLPHENOL Adrenergic alpha2C 96% 14.234uM 2.068uM View
arachidonate 15-lipoxygenase, second type ETOPOSIDE Lipoxygenase 15-LO 96% 3.187uM NoneNone View
arachidonate 15-lipoxygenase ETOPOSIDE Lipoxygenase 15-LO 96% 3.187uM NoneNone View
arachidonate 15-lipoxygenase ETOPOSIDE Lipoxygenase 15-LO 96% 3.187uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B AMITRIPTYLINE Serotonin 5-HT2B 96% .07uM .045uM View
calcium channel, voltage-dependent, gamma subunit 8 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 7 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 6 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 5 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 4 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 3 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 2 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, gamma subunit 1 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, beta 4 subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, beta 3 subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, beta 2 subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, alpha 1F subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, beta 1 subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 AMLODIPINE Calcium Channel Type L, Benzothiazepine 96% .101uM .09uM View
phosphodiesterase 3B TANNIC ACID Phosphodiesterase PDE3 96% .714uM NoneNone View
phosphodiesterase 3A TANNIC ACID Phosphodiesterase PDE3 96% .714uM NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) SULINDAC Aldose Reductase 96% .435uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) SULINDAC Aldose Reductase 96% .435uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) SULINDAC Aldose Reductase 96% .435uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) SULINDAC Aldose Reductase 96% .435uM NoneNone View
dopamine receptor D1A CHLORPROMAZINE Dopamine D1 96% .225uM .112uM View
thromboxane A synthase 1 TANNIC ACID Thromboxane Synthetase 96% .325uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) TANNIC ACID Thromboxane Synthetase 96% .325uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B U-78517F Serotonin 5-HT2B 96% .519uM .33uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CHLORPROMAZINE Adrenergic, Norepinephrine Transporter 96% .019uM .019uM View
dopamine receptor D4 CHLORPROMAZINE Dopamine D4.2 96% 1.365uM .479uM View
adrenergic receptor, alpha 2a AMIODARONE Adrenergic alpha2A 96% .312uM .117uM View
5-hydroxytryptamine (serotonin) receptor 2C AMIODARONE Serotonin 5-HT2C 96% .404uM .212uM View
melanocortin 3 receptor COLISTIN Melanocortin MC3 96% .193uM .168uM View
melanocortin 3 receptor COLISTIN Melanocortin MC3 96% .193uM .168uM View
5-hydroxytryptamine (serotonin) receptor 2C ERGONOVINE Serotonin 5-HT2C 96% .021uM .011uM View
5-hydroxytryptamine (serotonin) receptor 2B CISAPRIDE Serotonin 5-HT2B 96% .11uM .07uM View
5-hydroxytryptamine (serotonin) receptor 2B ERGONOVINE Serotonin 5-HT2B 96% .004139uM .002634uM View
adrenergic receptor, alpha 2b CLEMASTINE Adrenergic alpha2C 96% .095uM .014uM View
adrenergic receptor, alpha 2c (Non-specific probe) CLEMASTINE Adrenergic alpha2C 96% .095uM .014uM View
dopamine receptor 2 CLEMASTINE Dopamine D2L 96% .136uM .045uM View
adrenergic receptor, beta 1 CLENBUTEROL Adrenergic beta1 96% .12uM .069uM View
adrenergic, beta-1-, receptor CLENBUTEROL Adrenergic beta1 96% .12uM .069uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 CARVEDILOL Dopamine Transporter 96% .845uM .671uM View
adrenergic receptor, alpha 2a BENZOTHIAZYL DISULFIDE Adrenergic alpha2A 96% .899uM .337uM View
adrenergic receptor, beta 2 TIMOLOL Adrenergic beta2 96% .000292uM .000201uM View
A3 adenosine receptor THIMEROSAL Adenosine A3 96% 3.386uM 1.914uM View
opioid receptor, sigma 1 FLUOXETINE Sigma1 96% .499uM .21uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 TRAMADOL Serotonin Transporter 96% .372uM .198uM View
adrenergic receptor, beta 1 LABETALOL Adrenergic beta1 96% .01uM .005837uM View